Poging GOUD - Vrij
Tangled up in red tape: Can we really hope for relief?
Mint New Delhi
|February 14, 2025
Even the most globetrotting and good-natured of business executives are guaranteed to find India's rules and regulations bewildering.
This week, a chief executive visiting from London expressed frustration at the number of boarding-pass checks that had occurred at the airport in Jaipur. But the most absurd was having a boarding pass checked as he disembarked in Delhi. When he sought to get onto the airport wi-fi, an act as simple as turning on your phone at most airports overseas, he discovered that foreigners need a coupon to access wi-fi in Indian airports.
I could only nod in sympathy while trying to suppress my own post-traumatic stress disorder from complying with odd rules in the gilded fantasy palaces that our privately run airports have become. But privatizing airports and private airlines have not stopped India's love of rubber stamping from turning into an epidemic. At Bengaluru airport, Indigo Airlines will place a sticker on the back of your passport if you are flying abroad. The only explanation I have received is that this helps airport staff prevent domestic travellers from heading for international gates. Just moments after this conversation, however, I passed through a smart-scanner turnstile for international-flight gates that would almost certainly prevent this.
Dit verhaal komt uit de February 14, 2025-editie van Mint New Delhi.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint New Delhi

Mint New Delhi
Andreessen Horowitz to open office in Bengaluru
Andreessen Horowitz, one of the world's biggest venture capital funds, is setting up an office in Bengaluru, multiple people familiar with the development said.
2 mins
October 10, 2025

Mint New Delhi
Silver ETFs fired up by scarcity, festivals
Silver exchange traded funds or ETFs opened Thursday with a record 10-12% premium to spot prices, underscoring a scramble for the metal as festive buying, industrial use, and investor FOMO (fear of missing out) drove up demand against tight supplies.
2 mins
October 10, 2025
Mint New Delhi
AI BROKE THE INFO BOTTLENECK, BUT VALUE INVESTING STILL DEPENDS ON INSIGHT
In a Bloomberg column, Guy Spier argues that AI has ended the golden age of value investing by removing the old information edge.
3 mins
October 10, 2025

Mint New Delhi
TCS preps big pivot to AI, data centres
At least $6 bn investment in 6 yrs; Q2 revenue beats expectations
3 mins
October 10, 2025
Mint New Delhi
Celebrating the snake in jewellery and art
An exhibition in Mumbai reiterates the power of the serpent motif in ornamentation and shines a light on Jaipur's wealth of gemstones
2 mins
October 10, 2025
Mint New Delhi
Akasa co-founder Khatri exits after ₹1,200 cr funding
Ex-IAF officer's departure is the first from the founding team since the carrier's 2022 launch.
1 mins
October 10, 2025

Mint New Delhi
Razorpay to enter four new markets in South-East Asia
Initial public offering (IPO)-bound fintech major Razorpay is planning to expand into three to four new South-East Asian markets by the end of 2026, the firm's top executive told Mint in an interaction.
1 mins
October 10, 2025

Mint New Delhi
Silver ETFs soar on festive demand, supply crunch
\"In the past three to four weeks, we have seen a surge in silver demand,\" said Vikram Dhawan, head of commodities and fund manager at Nippon India Mutual Fund, which runs the largest gold and silver ETFs in the country.
2 mins
October 10, 2025

Mint New Delhi
Govt, IBBI eye checks on shady pre-bankruptcy business deals
The Union government is looking to tighten the noose around shady transactions at companies undergoing bankruptcy proceedings committed by previous managements, two people aware of the plans said.
1 mins
October 10, 2025
Mint New Delhi
American chill pill
America's new 100% pharma tariff, going by a recent post online by US President Donald Trump, was aimed at \"branded or patented\" pharmaceutical products, barring those for which plants were being built in the US.
1 min
October 10, 2025
Listen
Translate
Change font size